IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features — Stella

Recruiting

Back to Nasopharyngeal Cancinoma (NPC) trials

Trial locations(1 site)

China

Fujian Cancer Hospital, Fuzhou, Fujian

Key details

Sponsor

Qiaojuan Guo

Enrollment target

~169 participants

Started

January 2026

Primary completion

December 2030

Age range

18 Years – 70 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov